Patent directory · USPTO A61K / A61P
Patents matching “monoclonal”
203 pharma patents match "monoclonal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 203 pharmaceutical patents matching "monoclonal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10023650
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 9969803
Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof
granted -
US 9938344
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 9932406
Human monoclonal antibodies specific for glypican-3 and use thereof
granted -
US 9926380
Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
granted -
US 9902780
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted -
US 9845350
Monoclonal antibodies that react with the capsule of bacillus anthracis
granted -
US 9815887
Monoclonal antibodies that neutralize a norovirus
granted -
US 9803022
Mesothelin domain-specific monoclonal antibodies and use thereof
granted -
US 9790274
Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases
granted -
US 9783596
Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
granted -
US 9738726
HER2-specific monoclonal antibodies and conjugates thereof
granted -
US 9738720
Monoclonal antibodies against HER2 epitope and methods of use thereof
granted -
US 9725520
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted -
US 9708392
Monoclonal antibodies against orthopoxviruses
granted -
US 9676846
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted -
US 9663585
Anti-DCLK1 monoclonal antibodies and methods of production and use thereof
granted -
US 9605077
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 9598492
Human monoclonal antibodies specific for CD22
granted -
US 9593162
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
granted -
US 9592290
Monoclonal antibody therapy for pancreas cancer
granted -
US 9592238
Anti-ceramide monoclonal antibody 2A2
granted -
US 9580492
Monoclonal antibodies that neutralize anthrax toxins
granted -
US 9567402
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted